additional week of expectant management and delivery at 39 weeks. Maternal outcomes of interest were cesarean delivery, operative vaginal delivery, perineal tear, chorioamnionitis, and endomyometritis. Neonatal outcomes of interest were intrauterine fetal death, 5 minute Apgar less than 7, NICU admission, respiratory distress syndrome (RDS), hypoglycemia, hypoxic ischemic encephalopathy (HIE) and jaundice. Results were compared using chi square analysis and examined using multivariate logistic regression. A p-value of less than 0.05 was used to indicate statistical significance. RESULTS: In our cohort of 231,567 deliveries, there were significant differences in the incidence of cesarean delivery, perineal tears, chorioamnionitis, and endomyometritis in women who were electively induced at 38 weeks compared to those who received expectant management and delivered at 39 weeks. However, the rate of operative vaginal delivery was not significantly different between the two groups. The rate of intrauterine fetal death was also significantly decreased when women were electively induced at 38 weeks. Logistic regression analysis indicated expectant management for one additional week, with delivery at 39 weeks, significantly increased cesarean deliveries (OR 1.45, 95% CI 1.37-1.54) but decreased RDS in neonates (OR 0.83, 95% CI 0.71-0.98). There were no differences between the two groups for neonatal outcomes of hypoglycemia, HIE and jaundice. CONCLUSION: The maternal and neonatal outcomes following birth are associated with the timing and management prior to delivery. These findings can be used to counsel women regarding the risks of maternal and neonatal complications from elective induction of labor and expectant management for one additional week.
692 Obstructive sleep apnea is an unrecognized contributor to fatigue in pregnancy D'Angela S. Pitts, Patricia Greco, Louise M. O'Brien University of Michigan, Ann Arbor, MI OBJECTIVE: Pregnant women often complain of fatigue but this is generally thought to be part of pregnancy due to hormonal changes. In the non-pregnant population obstructive sleep apnea (OSA) is a known contributor to fatigue but this has not been investigated in pregnant women. We therefore examined whether underlying OSA plays a role in fatigue during pregnancy. STUDY DESIGN: A secondary analysis of home sleep tests conducted among pregnant women for research purposes. All women were queried about symptoms of fatigue and daytime sleepiness using a fatigue scale and the Epworth Sleepiness Scale respectively. Women who reported that they experienced fatigue "often" were classified as cases. Excessive daytime sleepiness was considered present with a sleepiness score of !10. The presence of OSA was determined by an overnight home sleep test with an apnea-hypopnea index of !5 events/hour. Demographics and medical information was obtained by chart abstraction. Regression analyses were constructed to determine key contributors to fatigue. RESULTS: The sample size included 84 pregnant women (mean age 31.3AE5.9 years, and mean gestational age 29.0AE7.6 weeks). Thirtysix percent of women reported that they were "often" fatigued, 46% screened positive for daytime sleepiness, and 42% had OSA. Demographics are shown in Table 1 . There was no association between fatigue and daytime sleepiness. In a logistic regression model, a complaint of fatigue was strongly associated with the presence of OSA (OR 5.1, 95%CI 1.4-19.3) after controlling for maternal age, gestational age, parity, BMI, race, and daytime sleepiness. CONCLUSION: Unrecognized OSA is a significant contributor to fatigue in pregnancy. Clinicians caring for pregnant women should consider OSA in women who are often fatigued. OBJECTIVE: Obesity has emerged as a leading cause of morbidity in reproductive aged women. It is associated with multiple maternal and fetal co-morbidities including pre-eclampsia, gestational diabetes and fetal growth restriction. It is also associated with obstructive sleep apnea (OSA), a treatable condition that is independently associated with gestational hypertension, pre-eclampsia, gestational diabetes, and fetal growth restriction. Despite the known association between obesity and OSA, pregnant women are rarely screened for OSA. Identification of high-risk women should be a priority in pregnancy as OSA can be treated. Thus, we investigated the relationship between the severity of obesity and the odds of objectively-assessed OSA. 
OBJECTIVE:
To evaluate the risk of postpartum endometritis, wound infections (WI) and breast abscess (BA) after different modes of delivery in overweight, obese and morbidly obese women compared to normal weight women. STUDY DESIGN: A population based observational study. All deliveries in Sweden during the years 2005 to 2012 (n¼ 841780) were included in the study. Data were collected from the Medical Birth Register, the Patient Register and the Prescribed Drugs Register, which are all validated and together have over 99 percent coverage during the study period. Postpartum endometritis, WI and BA were defined as the presence of applicable ICD-10 codes given within eight weeks postpartum. The reference population was women without infection diagnosis and without dispensed prescription of antibiotics within eight weeks postpartum. The women were categorized according to weight and height in early pregnancy into five Body Mass Index (BMI) classes. Odds ratios were determined using Mantel Haenszel technique, with adjustments for year of delivery, maternal age, parity and smoking in early pregnancy.
RESULTS:
There was a dose-dependent relationship between an increasing maternal BMI and a higher risk for postpartum infections, reaching a 50 percent increased risk in the morbidly obese group.
The risk of endometritis and WI increased whereas the risk of BA decreased with higher BMI-class. (Table 1) The risk of endometritis increased with higher BMI after normal vaginal delivery, but not after instrumental delivery or after caesarean section (CS). For morbidly obese women the OR:s and 95% CI after normal vaginal delivery, instrumental vaginal delivery and CS were respectively: 1.45 (1.29-1.63), 1.14 (0.77-1.69) and 1.12 (0.91-1.31). The risk of WI after CS increased with higher BMI and did not differ whether it was an elective or emergency CS. (Figure 1) The risk of BA after normal vaginal delivery and CS was reduced when BMI was higher, whereas it was the same in different BMIclasses after instrumental vaginal delivery. CONCLUSION: BMI was an independent risk factor for postpartum endometritis after normal vaginal delivery and for WI after CS. There was no difference in how BMI affected the risk of WI after CS whether it was a planned CS or an emergency CS. Obese women are at smaller risk of BA, which is probably attributed to the fact that obese women tend to breast feed at a lower extent.
